WHO ICTRP trial
Comparison of the effect of two compounds of Propofol-Remifentanil and…
IRCT20171030037093N30 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20171030037093N30 |
|---|---|
| Public title | Comparison of the effect of two compounds of Propofol-Remifentanil and Propofol-Hydralazine on volume of blood loss during dacryocystorhinostomy with general anesthesia |
| Scientific title | A comparative study on the effect of two compounds of Propofol-Remifentanil and Propofol-Hydralazine on volume of blood loss during dacryocystorhinostomy with general anesthesia |
| Primary sponsor | Esfahan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | Blood loss during surgery. |
| Interventions | Intervention 1: First intervention group:In group A in a 50 cc syringe 40 cc propofol with 0.15 µg / kg remifentanil is prepared and eventually the infusion at a dose of 50-150 µg/kg/min will be started. At the end of surgery, blood volume… |
| Registration date | Feb 5, 2020 |
| Target size | 80 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: